Search Results - "Pazgal, Idit"

Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel by Pazgal, Idit, Yahalom, Vered, Shalev, Bruria, Raanani, Pia, Stark, Pinhas

“…Patients with beta thalassemia major (TM) are transfusion-dependent (TD) since early childhood and for life. Development of alloantibodies and autoantibodies…”
Get full text

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia by Cappellini, M. Domenica, Viprakasit, Vip, Taher, Ali T, Georgiev, Pencho, Kuo, Kevin H.M, Coates, Thomas, Voskaridou, Ersi, Liew, Hong-Keng, Pazgal-Kobrowski, Idit, Forni, G.L, Perrotta, Silverio, Khelif, Abderrahim, Lal, Ashutosh, Kattamis, Antonis, Vlachaki, Efthymia, Origa, Raffaella, Aydinok, Yesim, Bejaoui, Mohamed, Ho, P. Joy, Chew, Lee-Ping, Bee, Ping-Chong, Lim, Soo-Min, Lu, Meng-Yao, Tantiworawit, Adisak, Ganeva, Penka, Gercheva, Liana, Shah, Farrukh, Neufeld, Ellis J, Thompson, Alexis, Laadem, Abderrahmane, Shetty, Jeevan K, Zou, Jun, Zhang, Jennie, Miteva, Dimana, Zinger, Tatiana, Linde, Peter G, Sherman, Matthew L, Hermine, Olivier, Porter, John, Piga, Antonio

“…Patients with transfusion-dependent β-thalassemia were randomly assigned to receive luspatercept (a binder for TGF-β family member ligands) or placebo. During…”
Get full text

High incidence of silent cerebral infarcts in adult patients with Beta thalassemia major by Pazgal, Idit, Inbar, Edna, Cohen, Maya, Shpilberg, Ofer, Stark, Pinhas

“…Abstract Objectives Survival of beta thalassemia major (TM) patients has improved significantly over the past few decades. Consequently, less commonly reported…”
Get full text

Reduced Number and Function of Endothelial Progenitor Cells in Patients with Beta Thalassemia Major by Spectre, Galia, Stark, Pinhas, Steimatzky, Arza, Raanani, Pia, Lev, Dorit, Kornowski, Ran, Pazgal, Idit

“…There is a high incidence of venous thromboembolic complications in patients with beta thalassemia .Recently, a high incidence of asymptomatic multiple silent…”
Get full text

Splenectomy in childhood for non‐malignant haematologic disorders – long‐term follow‐up shows minimal adverse effects by Yacobovich, Joanne, Barzilai‐Birenboim, Shlomit, Steinberg‐Shemer, Orna, Stark, Pinhas, Pazgal, Idit, Tamary, Hannah

“…Summary Splenectomy is considered therapeutic in various non‐malignant haematologic diseases. Adverse events ‒ specifically infections and thromboembolism ‒…”
Get full text

Long Term Outcome of Splenectomy in Pediatric Patients with Non-Malignant Hematological Diseases: Four Decades of Follow up by Yacobovich, Joanne, Barzilai-Birenboim, Shlomit, Stark, Pinhas, Pazgal, Idit, Steinberg-Shemer, Orna, Tamary, Hannah

“…Elective splenectomy in childhood can ameliorate the clinical manifestations of non-malignant hematological diseases such as beta-thalassemia, hereditary…”
Get full text

Genetic backgrounds and clinical characteristics of congenital neutropenias in Israel by Yeshareem, Lital, Yacobovich, Joanne, Lebel, Asaf, Noy‐Lotan, Sharon, Dgany, Orly, Krasnov, Tanya, Berger Pinto, Galit, Oniashvili, Nino, Mardoukh, Jacques, Bielorai, Bella, Laor, Ruth, Mandel‐Shorer, Noa, Ben Barak, Ayelet, Levin, Carina, Asleh, Mahdi, Miskin, Hagit, Revel‐Vilk, Shoshana, Levin, Dror, Benish, Marganit, Zuckerman, Tsila, Wolach, Ofir, Pazgal, Idit, Brik Simon, Dafna, Gilad, Oded, Yanir, Asaf David, Goldberg, Tracie Alison, Izraeli, Shai, Tamary, Hannah, Steinberg‐Shemer, Orna

“…Background Congenital neutropenias are characterized by severe infections and a high risk of myeloid transformation; the causative genes vary across…”
Get full text

Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias by Shefer Averbuch, Noa, Steinberg‐Shemer, Orna, Dgany, Orly, Krasnov, Tanya, Noy‐Lotan, Sharon, Yacobovich, Joanne, Kuperman, Amir A., Kattamis, Antonis, Ben Barak, Ayelet, Roth‐Jelinek, Batia, Chubar, Evgeni, Shabad, Evelyn, Dufort, Gustavo, Ellis, Martin, Wolach, Ofir, Pazgal, Idit, Abu Quider, Abed, Miskin, Hagit, Tamary, Hannah

“…Background Most patients with anemia are diagnosed through clinical phenotype and basic laboratory testing. Nonetheless, in cases of rare congenital anemias,…”
Get full text

Acquired proximal renal tubular dysfunction in β-thalassemia patients treated with deferasirox by Yacobovich, Joanne, Stark, Pinhas, Barzilai-Birenbaum, Shlomit, Krause, Irit, Pazgal, Idit, Yaniv, Isaac, Tamary, Hannah

“…Deferasirox is a recently approved oral iron chelator for treatment of patients with transfusion-related iron overload. Although renal function disturbances…”
Get full text

Thalassemia Major and Intermedia in Older Patients – a Single Center Experience by Shargian-Alon, Liat, Pazgal, Idit, Raanani, Pia, Rachmilewitz, Eliezer, Stark, Pinhas

“…Introduction Survival of beta thalassemia major (TM) and intermedia (TI) patients have improved significantly over the past few decades as better treatment and…”
Get full text

GFR in Patients with β-Thalassemia Major by Milo, Gai, Feige Gross Nevo, Revital, Pazgal, Idit, Gafter-Gvili, Anat, Shpilberg, Ofer, Gafter, Uzi, Erman, Arie, Stark, Pinhas

“…Patients with β-thalassemia major (TM) may have tubular dysfunction and glomerular dysfunction, primarily hyperfiltration, based on eGFR. Assessment of GFR…”
Get full text

Lactose intolerance is not the cause of gastrointestinal adverse effects in beta thalassemia patients treated with deferasirox by Pazgal, Idit, Brown, Marius, Perets, Tsachi Tsadok, Niv, Yaron, Rachmilewitz, Eliezer, Stark, Pinhas

Get full text

Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas by Pazgal, Idit, Boycov, Olga, Shpilberg, Ofer, Okon, Elimelech, Bairey, Osnat

“…Lymphangiogenesis-the new growth of lymphatic vessels is an important route for the metastatic spread of human cancer. The receptor tyrosine kinase VEGFR-3 is…”
Get full text

Transfusion service management of sickle-cell disease patients by Yazer, M.H., Lozano, M., Crighton, G., Greenway, A., Comande, M., Savoia, H., Wood, E., Gilli, S., Castilho, L., Saad, Sara T.O., Galactéros, F., Noizat-Pirenne, F., Pazgal, I., Stark, P., Orlin, Y., Perseghin, P., Masera, N., Cela, E., Anguita, J., Wikman, A., Delaney, M.

Get full text

Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect? by Ram, Ron, Gafter-Gvili, Anat, Okon, Elimelech, Pazgal, Idit, Shpilberg, Ofer, Raanani, Pia

“…Gelatinous marrow transformation (GMT) is an unusual pathological manifestation of progressive malignant diseases and severe malnutrition states. GMT has been…”
Get more information

Expression of VEGF-C and Its Receptor VEGFR-3 in Diffuse Large B-Cell Lymphomas by Pazgal, Idit, Boycov, Olga, Shpilberg, Ofer, Okon, E., Bairey, Osnat

“…Vascular endothelial growth factor (VEGF)-C and its receptor tyrosine kinase VEGFR-3 are critical regulators of lymphangiogenesis. Their expression has been…”
Get full text

Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma by Bairey, Osnat, Blickstein, Dorit, Monselise, Yehudit, Lahav, Judith, Stark, Pinhas, Prokocimer, Miron, Nativ, Hila Magen, Kirgner, Ilia, Pazgal, Idit, Shaklai, Mati

“…:  Objectives: Patients with malignancies have an increased prevalence of antiphospholipid antibodies (APA). The aim of this study was to determine the…”
Get full text

Alloimmunization and Autoimmunization in Adult Transfusion Dependent Beta Thalassemia Major Patients: Report from a Comprehensive Center in Israel by Pazgal-Kobrowski, Idit, Yahalom, Vered, Shalev, Bruria, Raanani, Pia, Stark, Pinhas

“…BACKROUND: Survival of patients with transfusion dependent (TD) beta thalassemia major (TM) has improved significantly over the past few decades as better…”
Get full text

Misleading Steal Phenomenon of Ga-67 Uptake by the Spleen in a Patient With Sarcoidosis by Stark, Pinhas, Pazgal, Idit, Bernstine, Hanna, Steinmetz, Adam

“…Sarcoidosis is a multisystemic granulomatous disease of unknown etiology. Most frequently, sarcoidosis presents with bilateral hilar lymphadenopathy and…”
Get full text

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions by Cappellini, Maria Domenica, Viprakasit, Vip, Taher, Ali, Georgiev, Pencho, Kuo, Kevin H.M., Coates, Thomas D., Voskaridou, Ersi, Liew, Hong Keng, Pazgal-Kobrowski, Idit, Forni, Gianluca, Perrotta, Silverio, Khelif, Abderrahim, Lal, Ashutosh, Kattamis, Antonis, Vlachaki, Efthymia, Origa, Raffaella, Aydinok, Yesim, Bejaoui, Mohamed, Ho, P. Joy, Chew, Lee Ping, Bee, Ping Chong, Lim, Soo Min, Lu, Meng-Yao, Tantiworawit, Adisak, Ganeva, Penka, Gercheva, Liana, Shah, Farrukh, Neufeld, Ellis J., Laadem, Abderrahmane, Shetty, Jeevan K., Zou, Jun, Miteva, Dimana, Zinger, Tatiana, Linde, Peter G., Sherman, Matthew L., Hermine, Olivier, Porter, John, Piga, Antonio

“…▪ Introduction: β-thalassemia is an inherited hemoglobinopathy associated with an erythroid maturation defect characterized by ineffective erythropoiesis and…”
Get full text